Phase I Study of C6 Ceramide NanoLiposome in Patients With Advanced Solid Tumors
Latest Information Update: 18 Jan 2024
At a glance
- Drugs Ceramide (Primary)
- Indications Liver cancer; Solid tumours
- Focus Adverse reactions; First in man
- Sponsors PendreaBio
- 26 Feb 2019 Planned End Date changed from 1 Mar 2019 to 1 Aug 2019.
- 26 Feb 2019 Planned primary completion date changed from 1 Mar 2019 to 1 Aug 2019.
- 28 Mar 2017 Planned primary completion date changed from 1 Sep 2018 to 1 Mar 2019.